Page last updated: 2024-08-24

gallocatechol and Iron Metabolism Disorders

gallocatechol has been researched along with Iron Metabolism Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abraham, B; Alayash, AI; Baek, JH; Buehler, PW; Manalo, DJ; Struble, E1

Other Studies

1 other study(ies) available for gallocatechol and Iron Metabolism Disorders

ArticleYear
Inactivation of prolyl hydroxylase domain (PHD) protein by epigallocatechin (EGCG) stabilizes hypoxia-inducible factor (HIF-1α) and induces hepcidin (Hamp) in rat kidney.
    Biochemical and biophysical research communications, 2011, Dec-16, Volume: 416, Issue:3-4

    Topics: Animals; Antimicrobial Cationic Peptides; Catechin; Cell Line; Gene Expression Regulation; Hepcidins; Hypoxia-Inducible Factor 1, alpha Subunit; Hypoxia-Inducible Factor-Proline Dioxygenases; Iron Metabolism Disorders; Kidney; Male; Procollagen-Proline Dioxygenase; Protein Stability; Protein Structure, Secondary; Protein Structure, Tertiary; Rats; Rats, Sprague-Dawley

2011